Respiratory infection in an immunocompromised person: Difference between revisions
From IDWiki
(Created page with "== Differential Diagnosis == === By Defect === {| class="wikitable" !Risk Factor !Differential Diagnosis !Investigations |- ! colspan="3" |Cell-Mediated Immunodeficiency |- |...") Â |
(→â€) |
||
| Line 1: | Line 1: | ||
== |
==Differential Diagnosis== |
||
=== |
===By Defect=== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Risk Factor |
!Risk Factor |
||
| Line 13: | Line 13: | ||
| rowspan="3" |sputum and blood culture, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, bronchoalveolar lavage, Toxoplasma/Cryptococcus PCR, induced sputum, beta-D glucan |
| rowspan="3" |sputum and blood culture, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, bronchoalveolar lavage, Toxoplasma/Cryptococcus PCR, induced sputum, beta-D glucan |
||
|- |
|- |
||
|Hairy cell leukemia, acute T-cell leukemia, T-cell lymphoma |
|[[Hairy cell leukemia]], [[acute T-cell leukemia]], [[T-cell lymphoma]] |
||
|- |
|- |
||
|Fludarabine, ibrutinib, alemtuzumab |
|[[Fludarabine]], [[ibrutinib]], [[alemtuzumab]] |
||
|- |
|||
|[[HIV]] |
|||
| |
|||
| |
|||
|- |
|- |
||
! colspan="3" |Humoural Immunodeficiency |
! colspan="3" |Humoural Immunodeficiency |
||
| Line 25: | Line 29: | ||
|Complement deficiency |
|Complement deficiency |
||
|- |
|- |
||
|Common variable immunodeficiency |
|[[Common variable immunodeficiency]] |
||
|- |
|- |
||
|Rituximab and other anti-CD20 therapy |
|[[Rituximab]] and other anti-CD20 therapy |
||
|- |
|- |
||
|Multiple myeloma and CLL |
|[[Multiple myeloma]] and [[CLL]] |
||
|- |
|- |
||
! colspan="3" |Phagocyte Defects |
! colspan="3" |Phagocyte Defects |
||
| Line 37: | Line 41: | ||
| rowspan="5" |sputum and blood cultures, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, [[β-D glucan]] and [[galactomannan]], Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
| rowspan="5" |sputum and blood cultures, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, [[β-D glucan]] and [[galactomannan]], Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
||
|- |
|- |
||
|Neutropenia |
|[[Neutropenia]] |
||
|- |
|- |
||
|Myelodysplastic syndrome |
|[[Myelodysplastic syndrome]] |
||
|- |
|- |
||
|Acute myelogenous leukemia |
|[[Acute myelogenous leukemia]] |
||
|- |
|- |
||
|Allogeneic hematopoietic stem cell transplantation |
|[[Allogeneic hematopoietic stem cell transplantation]] |
||
|} |
|} |
||
=== |
===By CT Pattern=== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Pattern |
!Pattern |
||
| Line 81: | Line 85: | ||
|} |
|} |
||
== |
==Further Reading== |
||
* |
*Diagnosis of severe respiratory infections in immunocompromised patients. ''Intensive Care Med''. 2020;46:298-314. doi: [https://doi.org/10.1007/s00134-019-05906-5 10.1007/s00134-019-05906-5] |
||
[[Category:Immunocompromised hosts]] |
[[Category:Immunocompromised hosts]] |
||
Revision as of 01:45, 16 February 2021
Differential Diagnosis
By Defect
| Risk Factor | Differential Diagnosis | Investigations |
|---|---|---|
| Cell-Mediated Immunodeficiency | ||
| Steroids and solid organ transplantation | opportunistic infections, systemic viruses, Pneumocystis, Cryptococcus, Mycobacteria, Toxoplasma | sputum and blood culture, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, bronchoalveolar lavage, Toxoplasma/Cryptococcus PCR, induced sputum, beta-D glucan |
| Hairy cell leukemia, acute T-cell leukemia, T-cell lymphoma | ||
| Fludarabine, ibrutinib, alemtuzumab | ||
| HIV | ||
| Humoural Immunodeficiency | ||
| Splenectomy and asplenism | bacterial pneumonia (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) | sputum and blood cultures, antigenuria, multiplex viral PCR |
| Complement deficiency | ||
| Common variable immunodeficiency | ||
| Rituximab and other anti-CD20 therapy | ||
| Multiple myeloma and CLL | ||
| Phagocyte Defects | ||
| Steroids and solid organ transplantation | systemic viruses, Aspergillus, Mycobacteria, Nocardia, Mucorales, Toxoplasma | sputum and blood cultures, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, β-D glucan and galactomannan, Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
| Neutropenia | ||
| Myelodysplastic syndrome | ||
| Acute myelogenous leukemia | ||
| Allogeneic hematopoietic stem cell transplantation | ||
By CT Pattern
| Pattern | Differential Diagnosis | Investigations |
|---|---|---|
| nodular lesions | bacterial pneumonia, Aspergillus, Nocardia, Mucorales | sputum and blood cultures, antigenuria, sputum with fungal culture, Aspergillus/Mucorales PCR, galactomannan and β-D glucan, bronchoalveolar lavage |
| septal thickening | atypical bacterial pneumonia | sputum and blood cultures, antigenuria, bronchoalveolar lavage |
| cavitations | Mycobacteria, Histoplasma, bacterial pneumonia including Staphylococcus aureus | sputum and blood cultures, mycobacterial culture, Histoplasma PCR |
| excavated nodules | bacterial pneumonia, Mucorales, Nocardia, Actinomyces, Aspergillus | sputum and blood cultures, Aspergillus/Nocardia/Mucorales PCR, galactomannan and β-D glucan |
| consolidation | bacterial pneumonia, Aspergillus | sputum and blood cultures, antigenuria, sputum for fungal culture, galactomannan and β-D glucan |
| pleural effusion | bacterial pneumonia, tuberculosis | sputum and blood cultures, antigenuria, mycobacterial blood culture, pleural aspiration and culture |
| ground glass opacities | Pneumocystis, viral pneumonia, atypical bacterial pneumonia | sputum and blood culture, Legionella antigenuria, sputum for Pneumocystis, β-D glucan, multiplex viral PCR, CMV/VZV/HSV blood PCR, bronchoalveolar lavage |
Further Reading
- Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46:298-314. doi: 10.1007/s00134-019-05906-5
